DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed

Conditions: Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Cytogenetic Abnormality
Gene Abnormality

Interventions: Drug: VAH regimen
Drug: VEN+HMA regimen

First Posted Date: 2022-07-13

Last Posted Date: 2022-07-13

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 231

Registration Number: NCT05456048

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

Conditions: Acute Stroke

Interventions: Other: Observational study, no intervention

First Posted Date: 2022-07-12

Last Posted Date: 2022-07-12

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 2000

Registration Number: NCT05454397

Locations: 🇨🇳
The First People'S Hospital of Kunshan, Kunshan, Jiangsu, China
🇨🇳
Qilu Hospital of Shandong University(Qingdao), Qingdao, Shandong, China
🇨🇳
Red Cross Hospital of Hangzhou, Hangzhou, Zhejiang, China

and more 31 locations

Intermittent Eating on Sustaining Weight-loss in Obesity

Not Applicable

Recruiting

Conditions: Obesity

Interventions: Behavioral: Time-restricted eating

First Posted Date: 2022-07-12

Last Posted Date: 2023-11-09

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 270

Registration Number: NCT05453617

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Phase 2

Recruiting

Conditions: Myelodysplastic Syndrome
Allogeneic Hematopoietic Stem Cell Transplantation
Conditioning

Interventions: Drug: Granulocyte Colony-Stimulating Factor(G-CSF)
Drug: Decitabine (DAC)
Drug: Busulfan
Drug: Fludarabine (FLU)
Drug: Busulfan (BU)
Drug: Cyclophosphamide (CY)

First Posted Date: 2022-07-12

Last Posted Date: 2023-03-21

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 242

Registration Number: NCT05453552

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Safety of OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method

Not Applicable

Recruiting

Conditions: Gastric Cancer

Interventions: Procedure: OGT group
Procedure: Overlap group

First Posted Date: 2022-07-11

Last Posted Date: 2022-11-04

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 312

Registration Number: NCT05450835

Locations: 🇨🇳
Xinhua Chen, Guangzhou, Guangdong, China

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT

Phase 2

Recruiting

Conditions: Conditioning
Secondary Acute Myeloid Leukemia Evolving From MDS
Allogeneic Hematopoietic Stem Cell Transplantation

Interventions: Drug: Granulocyte Colony-Stimulating Factor(G-CSF)
Drug: Decitabine (DAC)
Drug: Busulfan (BU)
Drug: Fludarabine (FLU)
Drug: Cyclophosphamide (CY)

First Posted Date: 2022-07-08

Last Posted Date: 2022-07-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 232

Registration Number: NCT05449899

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

CAPD Versus APD in Nondiabetic Peritoneal Dialysis Patients

Not Applicable

Recruiting

Conditions: Peritoneal Dialysis

Interventions: Procedure: Group A and Group B

First Posted Date: 2022-07-08

Last Posted Date: 2025-04-03

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 216

Registration Number: NCT05449067

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

Safety and Efficacy of OGT Method Versus the Traditional Overlap Method

Completed

Conditions: Gastric Cancer

Interventions: Procedure: The conventional overlap method
Procedure: The overlap guiding tube(OGT) method

First Posted Date: 2022-07-05

Last Posted Date: 2022-07-05

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 155

Registration Number: NCT05442502

Locations: 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China

REmimazolam vs PrOpofol on Intraoperative hypotenSion in Major Noncardiac surgEry

Phase 4

Completed

Conditions: Intraoperative Hypotension

Interventions: Drug: Propofol
Drug: Remimazolam

First Posted Date: 2022-06-29

Last Posted Date: 2025-02-06

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 340

Registration Number: NCT05436522

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, China

Rapid Improvement of Depression of Fluoxetine Combined With ATP

Phase 2

Recruiting

Conditions: Depression

First Posted Date: 2022-06-24

Last Posted Date: 2023-11-15

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 195

Registration Number: NCT05431413

Locations: 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy